Skip to main content
Caplight Logo









FELIQS Corporation

FELIQS Corporation

Private
FukuokaHealthcare & Life Scienceshttps://feliqs.com/

Last Round

Series A

Jul 1, 2025

Total Funding Raised

$12.5M

Company Overview

FELIQS Corporation is a biotechnology company that develops small-molecule therapeutics targeting oxidized lipids and ferroptosis to treat ophthalmological and neonatal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyophthalmologydrug discoverysmall-molecule therapeuticsretinopathy of prematurityROPferroptosislipid peroxidationgeographic atrophyage-related macular degenerationAMDclinical trialsbiotech startuporphan drugdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FELIQS Corporation Comparables

Compare FELIQS Corporation with similar companies based on industry and business-model similarity.

FELIQS Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeaBeLife
79%
orphanix GmbH
78%
PulseSight Therapeutics
77%

FELIQS Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2025

Key People

Founding team and executive leadership

ken-ichiro Kuninobu

Co-Founder and CEO

Founding Team

Matt Fowler

Contract CFO

Executive Team

FELIQS Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    $10M round led by Beyond Next Ventures.

FELIQS Corporation Filings

Explore SEC and related filing metadata, where available.

FELIQS Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about FELIQS Corporation's valuation, stock price, and market status.

Is FELIQS Corporation a public or private company?

FELIQS Corporation is a private company.

What is the current stock price of FELIQS Corporation?

FELIQS Corporation is a private company with no public stock price. No recent secondary market data is available.

How much is FELIQS Corporation worth (valuation)?

Valuation information for FELIQS Corporation is not publicly available.

Can I buy FELIQS Corporation stock?

FELIQS Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was FELIQS Corporation's last funding round?

FELIQS Corporation's most recent funding round was Series A on July 1, 2025.

Who are the main investors in FELIQS Corporation?

Key investors in FELIQS Corporation include Beyond Next Ventures.

Will FELIQS Corporation IPO soon?

No public IPO plans have been announced for FELIQS Corporation.

How can I track FELIQS Corporation secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FELIQS Corporation's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFukuoka
Employee Range6
Year Founded2019
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?